中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
24期
115-116
,共2页
张超%王娇%陈蕊%陈自盈
張超%王嬌%陳蕊%陳自盈
장초%왕교%진예%진자영
阿维A%甲氨蝶呤%泛发性脓疱型%红皮病型银屑病%疗效%安全
阿維A%甲氨蝶呤%汎髮性膿皰型%紅皮病型銀屑病%療效%安全
아유A%갑안접령%범발성농포형%홍피병형은설병%료효%안전
Avi A%Methotrexate%Pustular type%Erythrodermic psoriasis%Efficacy%Safety
目的:进行阿维A与甲氨蝶呤治疗泛发性脓疱型和红皮病型银屑病的疗效及安全分析。方法随机选取该院2009年4月-2014年3月收治泛发性脓疱型和红皮病型银屑病患者200例随机分组,对照组患者给予阿维A治疗,观察组患者给予甲氨蝶呤治疗,对比疗效和安全性。结果对照组中泛发性脓疱型银屑病患者总有效率为94.0%;红皮病型银屑病患者总有效率为78.0%。观察组中泛发性脓疱型银屑病患者总有效率为76.0%;红皮病型银屑病患者总有效率为98.0%。两组的总治疗效果差异无统计学意义(P>0.05)。观察组患者不良反应明显少于对照组(P<0.05)。结论从疗效上看,阿维A与甲氨蝶呤治疗泛发性脓疱型和红皮病型银屑病的疗效相当,但阿维A治疗泛发性脓疱型银屑病患者效果更为显著,而甲氨蝶呤治疗红皮病型银屑病患者效果更显著,两者在治疗上有偏侧点,需要根据银屑病的类型进行选择。而从安全性方面来看,甲氨蝶呤安全性更高。
目的:進行阿維A與甲氨蝶呤治療汎髮性膿皰型和紅皮病型銀屑病的療效及安全分析。方法隨機選取該院2009年4月-2014年3月收治汎髮性膿皰型和紅皮病型銀屑病患者200例隨機分組,對照組患者給予阿維A治療,觀察組患者給予甲氨蝶呤治療,對比療效和安全性。結果對照組中汎髮性膿皰型銀屑病患者總有效率為94.0%;紅皮病型銀屑病患者總有效率為78.0%。觀察組中汎髮性膿皰型銀屑病患者總有效率為76.0%;紅皮病型銀屑病患者總有效率為98.0%。兩組的總治療效果差異無統計學意義(P>0.05)。觀察組患者不良反應明顯少于對照組(P<0.05)。結論從療效上看,阿維A與甲氨蝶呤治療汎髮性膿皰型和紅皮病型銀屑病的療效相噹,但阿維A治療汎髮性膿皰型銀屑病患者效果更為顯著,而甲氨蝶呤治療紅皮病型銀屑病患者效果更顯著,兩者在治療上有偏側點,需要根據銀屑病的類型進行選擇。而從安全性方麵來看,甲氨蝶呤安全性更高。
목적:진행아유A여갑안접령치료범발성농포형화홍피병형은설병적료효급안전분석。방법수궤선취해원2009년4월-2014년3월수치범발성농포형화홍피병형은설병환자200례수궤분조,대조조환자급여아유A치료,관찰조환자급여갑안접령치료,대비료효화안전성。결과대조조중범발성농포형은설병환자총유효솔위94.0%;홍피병형은설병환자총유효솔위78.0%。관찰조중범발성농포형은설병환자총유효솔위76.0%;홍피병형은설병환자총유효솔위98.0%。량조적총치료효과차이무통계학의의(P>0.05)。관찰조환자불량반응명현소우대조조(P<0.05)。결론종료효상간,아유A여갑안접령치료범발성농포형화홍피병형은설병적료효상당,단아유A치료범발성농포형은설병환자효과경위현저,이갑안접령치료홍피병형은설병환자효과경현저,량자재치료상유편측점,수요근거은설병적류형진행선택。이종안전성방면래간,갑안접령안전성경고。
Objective The curative effect and safety analysis of avermectin A and methotrexate in the treatment of generalized pustular and erythrodermic psoriasis. Methods The 200 patients were randomized into the hospital in 2009 April -2014 year in March from generalized pustular and erythrodermic psoriasis, the control group were treated with acitretin A treatment, observation group were treated with methotrexate treatment, comparing the efficacy and safety. Results In the control group, pustular psoriasis, the total effective rate was 94.0%; erythrodermic psoriasis patients, the total effective rate was 78.0%. Observation group pustular psoriasis patients, the total effective rate was 76.0%;erythrodermic psoriasis patients, the total effective rate was 98.0%. No signif-icant difference in the overall therapeutic effect of the two groups (P>0.05). Adverse reactions observed in patients was significant-ly less than the control group (P<0.05). Conclusion From the perspective effect, Avi A and methotrexate therapy generalized pus-tular and erythrodermic psoriasis quite, but Avi A treatment of generalized pustular psoriasis is more effective is significant, and methotrexate therapy in patients with erythrodermic psoriasis more significant effect, both in the treatment of unilateral point, you need to be selected according to the type of psoriasis. From the safety point of view, methotrexate higher security.